Clinical Trial Update: Methods Study to Evaluate Use of Cardiac Ultrasound to Assess Heart Valve Abnormality in People.

View source ↗

Summary

Pfizer-sponsored methods study evaluating the use of cardiac ultrasound to assess heart valve abnormalities; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Valvular Heart Disease

Snippet

Sponsor: Pfizer | Conditions: Heart Valve Diseases | Status: COMPLETED